Navigation Links
ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met,Inhibitor, for Oral Presentation at ASCO

WOBURN, Mass.--(BUSINESS WIRE)--Mar 14, 2007 - ArQule, Inc. (NASDAQ: ARQL) today announced that the American Society of Clinical Oncology (ASCO) has accepted for oral presentation the Company's abstract for ARQ 197 (A Phase 1 Dose Escalation Study of ARQ 197, a Selective Inhibitor of the c-Met Receptor in Patients with Metastatic Solid Tumors) at the 43rd ASCO Annual Meeting, June 1-5, 2007, in Chicago. This presentation will describe findings from a Phase 1 trial with ARQ 197, a selective, small molecule inhibitor of the c-Met receptor tyrosine kinase, in cancer patients with a broad range of metastatic solid tumor types who had failed prior treatment regimens.

In addition, abstracts describing protocol design and patient recruitment as of January, 2007 in the Company's ongoing Phase 2 trials with ARQ 501 in leiomyosarcoma and pancreatic cancer have been accepted for publication in the ASCO Proceedings. The Company expects to announce further results from these trials, as well as from a Phase 2 trial in head and neck cancer, in mid-2007. ARQ 501 is an activator of the DNA damage response/checkpoint pathway regulated by the E2F-1 regulatory protein and is the lead product from the Company's Activated Checkpoint Therapy (ACT) platform.

The American Association for Cancer Research (AACR) has accepted eleven abstracts submitted by the Company in connection with AACR's 2007 Annual Meeting, April 14-18, 2007, in Los Angeles. The AACR abstracts are based on pre-clinical studies that cumulatively provide a rationale for the company's approaches to cancer therapy as embodied in its c-Met inhibition and DNA damage response/checkpoint activation platforms. They represent a broad scope of findings from in vitro (cell line) and in vivo (animal) experiments.

Consistent with the disclosure policies mandated by ASCO and AACR, ArQule will summarize the contents of these studies at the time the complete abstracts
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:1/23/2015)... FORT MYERS, Fla. , Jan. 23, 2015  Today ... approval of Novartis, Bexsero® for the prevention of ... to 25. Bexsero and Pfizer,s vaccine Trumenba®, which received ... in helping prevent this devastating disease. ...
(Date:1/23/2015)... to Fight Chronic Disease (PFCD) released a public opinion poll of ... study analyzing the impact of increased cost sharing on patient adherence ... educate policy makers and the public on the costs of chronic ... the Iowa healthcare exchange could be improved ...
(Date:1/23/2015)... than a third of reproductive-aged women enrolled in Medicaid, and ... a prescription for an opioid pain medication each year during ... Mortality Weekly Report (MMWR). Opioids are typically ... pain.  They are also found in some prescription cough medications. ...
Breaking Medicine Technology:The National Meningitis Association (NMA) Applauds FDA Approval of Second Vaccine To Protect Against Serogroup B Meningococcal Disease 2New research shows Iowa health exchange would benefit from improvements 2New research shows Iowa health exchange would benefit from improvements 3Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3
... NEW YORK, Oct. 25, 2011 Reportlinker.com ... is available in its catalogue: ... http://www.reportlinker.com/p090623/Global-Eyeglasses-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Ophthalmic_Devices This report ... Million Units and US$ Million by the ...
... SAN DIEGO, Oct. 25, 2011 Aethlon ... developing therapeutic filtration devices to address infectious disease ... A. Joyce will present a company overview, discuss ... medical device partnering conference: Investment-In-Innovation (IN3) SUMMIT on ...
Cached Medicine Technology:Global Eyeglasses Industry 2Global Eyeglasses Industry 3Global Eyeglasses Industry 4Global Eyeglasses Industry 5Global Eyeglasses Industry 6Global Eyeglasses Industry 7Global Eyeglasses Industry 8Global Eyeglasses Industry 9Global Eyeglasses Industry 10Global Eyeglasses Industry 11Global Eyeglasses Industry 12Global Eyeglasses Industry 13Aethlon Medical to Present at IN3 Medical Innovation Summit on October 27th 2
(Date:1/22/2015)... (PRWEB) January 22, 2015 The Incredible Bulk ... Ben Pakulski to increase lean muscle by up to 30lbs ... caught the attention of HealthyandFitZone.com’s Stan Stevenson, prompting an investigative ... it is a step-by-step, scientific diet formula that allows the ...
(Date:1/22/2015)... Florida (PRWEB) January 22, 2015 Juvent ... today at the 2015 PGA Merchandise Show to bestow ... and incredible female amateur golfer, Arlene McKitrick. The award ... female amateur golf tournament win. She won her first ...
(Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post ... insurance . , Purchasing an accidental death and dismemberment ... This type of rider provides benefits if the insured dies ... a lesser form of life insurance. , AD&D is ...
(Date:1/22/2015)... Palm City, Florida (PRWEB) January 22, 2015 ... use cold therapy machine with patented IsoTube design to treat ... has introduced the most progressive and easy to use ... help treat post-operative and sports related orthopedic and muscle injuries. ...
(Date:1/22/2015)... JJsHouse.com is a famous dress online store for wedding dresses ... latest collection of wedding dresses , and launches a site-wide ... wedding dress on your big day; the wedding gown is ... wants to find the most suitable wedding dress. Now, we ...
Breaking Medicine News(10 mins):Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2
... SANTA ANA, Calif., June 26 Grubb & ... SouthCrest Medical Plaza, a,two- building medical office property ... Located at 1035 and 1045 Southcrest Drive, SouthCrest ... gross leaseable area,situated on approximately 9.7 acres of ...
... Center within the Herbert Irving Comprehensive Cancer Center at ... recruiting patients for a clinical research study of a ... a cancer of the lung,s lining that is almost ... standard treatment for pleural mesothelioma is currently surgery to ...
... 26, 2008)Recombinant human erythropoietin (rHuEpo) is a genetically engineered ... and marathon runners to boost their endurance. The potential ... from athletes. Since the test was introduced in 2000, ... the World Anti-Doping Agency (WADA) to administer the procedure. ...
... only way to flatten the,trajectory of healthcare spending ... last week,s I3 (insight, innovation and impact) Conference,sponsored ... keynote speaker,Wally Gomaa, president of Trajectory Health, effectively ... begin (or continue) working,together to positively impact the ...
... Company Holds Launch Events Throughout Cities in Guangdong and Guangxi ... ... Pa., June 26 /Xinhua-PRNewswire-FirstCall/ -- BMP,Sunstone Corporation (Nasdaq: BJGP; "BMP Sunstone" ... People,s Republic of,China. The Company will market and distribute Ferriprox under ...
... YORK, June 26 Golf pro, Jane Park, 21,of ... Open, is helping to,raise awareness for Parkinson,s disease. She ... J. Fox Foundation to help fund critically needed,Parkinson,s research. ... 26-29, will be her inaugural fundraising event as a ...
Cached Medicine News:Health News:Grubb & Ellis Healthcare REIT Acquires SouthCrest Medical Plaza in Stockbridge, Ga. 2Health News:Grubb & Ellis Healthcare REIT Acquires SouthCrest Medical Plaza in Stockbridge, Ga. 3Health News:New clinical trial for patients with asbestos-associated lung cancer 2Health News:New study examines the validity of epo testing 2Health News:New study examines the validity of epo testing 3Health News:Aegis Health Group Revealed Next Generation of Employer-Based Health-Improvement Strategies at Nashville Conference 2Health News:BMP Sunstone Announces Official Launch of Ferriprox in PRC 2Health News:BMP Sunstone Announces Official Launch of Ferriprox in PRC 3Health News:LPGA Golfer Jane Park to Raise Funds for Michael J. Fox Foundation for Parkinson's Research 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: